Does preoperative CSF Aβ/tau ratio identify patients at higher risk for cognitive changes after surgery?
Preoperative CSF Aβ/tau ratio may serve as a biomarker to identify patients at higher risk for cognitive decline following surgery.
Preoperative CSF Aβ/tau ratio is associated with postoperative changes in specific cognitive domains. The presence of the Alzheimer's disease biomarker, specifically the Aβ/tau ratio, may identify patients at higher risk for cognitive changes after surgery.
Xie et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: